Wednesday, Dec 13, 2023 · SEC filings
What the smart money revealed on Dec 13
545 insider filings came in. We hid 57 planned (10b5-1) sellers and 271 people whose filings were routine, like grants and tax withholding.
Wave Life Sciences (WVE) Director Peter Kolchinsky bought $5M
1M shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.
Terex (TEX) Director David Sachs bought $2.55M
50,000 shares on the open market. Not a grant or an option exercise.
Biglari (BH) Chairman and CEO Sardar Biglari bought $2.13M
Open-market buys of more than one share class. Not a grant or an option exercise. Their past buys: 4 of 5 checked quarters beat the typical stock 6 months later.
Heartland Express (HTLD) CEO Michael Gerdin bought $1.15M
82,509 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.
TransDigm Group (TDG) Director Robert Small sold $18.5M
Not marked as a planned 10b5-1 sale. Sold 10% of the shares they held directly. Still holds 158,858 shares.
DraftKings (DKNG) President - DraftKings Matthew Kalish sold $17.7M
Not marked as a planned 10b5-1 sale. Sold 7% of the shares they held directly. Still holds 6.47M shares.
Moog (MOG-A) Vice President Maureen Athoe sold $872K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 54 more real buys
Show 102 more real sales
13F season
Holdings as of Sep 30, 2023 were due Nov 14
40 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Dec 7–13
Open-market buys by officers and directors, filed in the 7 days up to Dec 13.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.